Trademark: SYNERGIE GENE+ OUTCOMES
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
SYNERGIE GENE+ OUTCOMES
Click here to search for trademarks similar to SYNERGIE GENE+ OUTCOMES
Proof of use for SYNERGIE GENE+ OUTCOMES
We do not have any records of a proof of use for SYNERGIE GENE+ OUTCOMES at this moment.
Click here to add a proof of use for SYNERGIE GENE+ OUTCOMES
Possible trademark infringements of SYNERGIE GENE+ OUTCOMES
Basic Information about SYNERGIE GENE+ OUTCOMES
- Serial Number
- 98055817
- Filing Date
- 23 Jun 2023
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of SYNERGIE GENE+ OUTCOMES on the blockchain with WikiTrademarks.io.
- First use of SYNERGIE GENE+ OUTCOMES anywhere
- SYNERGIE GENE+ OUTCOMES was first used on 15 Dec 2023 for the primary classification of goods and services, international, 035 (Advertising and business)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 035
- US Codes
- 100; 101; 102
Who owns SYNERGIE GENE+ OUTCOMES?
1. Synergie Medication Collective, LLC Wilmington DE
2. Synergie Medication Collective, LLC Wilmington DE
Correspondent
- Patricia I. Reding FAEGRE DRINKER BIDDLE & REATH LLP
- 90 S. Seventh Street, Suite 2200
- Minneapolis, MN 55402
- United States
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io